首页> 美国卫生研究院文献>Journal of Biomolecular Techniques : JBT >P169-S Rapid and Sensitive Identification of Amyloid Proteins from Formalin-Fixed Paraffin-Embedded Sections and Fat Aspirates: Potential for Aiding in Clinical Diagnosis of Systemic Amyoidosis
【2h】

P169-S Rapid and Sensitive Identification of Amyloid Proteins from Formalin-Fixed Paraffin-Embedded Sections and Fat Aspirates: Potential for Aiding in Clinical Diagnosis of Systemic Amyoidosis

机译:P169-S快速和灵敏的鉴定从福尔马林固定石蜡包埋的切片和脂肪抽吸物中的淀粉样蛋白:有助于系统性淀粉样变性病临床诊断的潜力

代理获取
本网站仅为用户提供外文OA文献查询和代理获取服务,本网站没有原文。下单后我们将采用程序或人工为您竭诚获取高质量的原文,但由于OA文献来源多样且变更频繁,仍可能出现获取不到、文献不完整或与标题不符等情况,如果获取不到我们将提供退款服务。请知悉。

摘要

Human amyloidosis describes a condition where one of some 23 known proteins form non-soluble pathological fibrils in various organs and tissues throughout the body. A common feature of these amyloid deposits is distinctive green birefringence when stained with Congo Red. Staining is performed on formalin fixed paraffin embedded (FFPE) tissue sections of tissue biopsies or on subcutaneous abdominal fat aspirates. This method is combined with clinical, immunohistochemical, and genetic information to diagnose the condition and in some cases, identify the amyloid involved. Definitive identification of the amyloid protein is essential for proper therapies in treating patients. Identification in the cases where the other methods give ambiguous results, involve solubilizing and extracting the amyloid proteins from the fixed sections or from fat aspirates. In an attempt to reduce the processing time of these types of clinical samples and still provide definitive identification, we explored in-situ enzymatic digestion methods that exploit the speed and sensitivity of nanoRPLC-ESI-tandem mass spectrometry. Using previously diagnosed clinical samples, we tested a variety of conditions to perform trypsin digestion directly on laser capture microdisected (LCM) generated samples and on fat aspirate samples with the goal of having a robust method suitable for mass spectrometry based identification. Trypsin digestions were performed using, ammonioum bicarbonate, Tris, Tris EDTA/ ± zwittergent 3–16, with and without solubilization steps of hexafluoroisopropanol, acetonitrile, or DMSO. A commercially available FFPE solubilization kit, Liquid Tissue, was also tested. The efficacies of these treatments are judged by performing Sequest or Mascot searches of LTQ generated MS/MS spectra, noting the presence of peptides from the expected amyloid proteins. This method has been successfully utilized to correctly identify amyloids comprised of transthyretin (TTR), serum amyloid A (SAA), lambda and kappa light chains. Controls taken from regions adjacent to the amyloid plaques were consistently devoid of the amyloid proteins.
机译:人类淀粉样变性描述了一种状况,其中约23种已知蛋白质中的一种在人体的各个器官和组织中形成非可溶​​性病理原纤维。这些淀粉样沉积物的一个共同特征是用刚果红染色时具有独特的绿色双折射。在组织活检组织的福尔马林固定石蜡包埋(FFPE)组织切片或皮下腹部脂肪抽吸物上进行染色。该方法与临床,免疫组化和遗传信息相结合,以诊断疾病,并在某些情况下,确定涉及的淀粉样蛋白。淀粉样蛋白的明确鉴定对于治疗患者的正确治疗至关重要。在其他方法给出歧义结果的情况下,鉴定涉及从固定部分或脂肪抽吸物中溶解和提取淀粉样蛋白。为了减少这些类型的临床样品的处理时间并仍然提供确定的标识,我们探索了利用nanoRPLC-ESI串联质谱的速度和灵敏度的原位酶消化方法。使用先前诊断的临床样本,我们测试了多种条件,可直接在激光捕获显微切割(LCM)生成的样本和脂肪抽吸样本上直接进行胰蛋白酶消化,目的是拥有一种适用于基于质谱的鉴定的可靠方法。使用碳酸氢铵,Tris,Tris EDTA /±两性离子3-16进行胰蛋白酶消化,有或没有六氟异丙醇,乙腈或DMSO的增溶步骤。还测试了市售FFPE增溶试剂盒Liquid Tissue。通过对LTQ生成的MS / MS谱图进行Sequest或Mascot搜索来判断这些处理的有效性,并注意存在来自预期淀粉样蛋白的肽。该方法已成功地用于正确鉴定由运甲状腺素蛋白(TTR),血清淀粉样蛋白A(SAA),λ和kappa轻链组成的淀粉样蛋白。从与淀粉样蛋白斑块相邻的区域获得的对照始终不含淀粉样蛋白。

著录项

相似文献

  • 外文文献
代理获取

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号